0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Research Report 2023
Published Date: January 2023
|
Report Code: QYRE-Auto-37C12056
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global 10 Valent Pneumococcal Polysaccharide Vaccine Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Research Report 2023

Code: QYRE-Auto-37C12056
Report
January 2023
Pages:90
QYResearch
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market

23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine is for use only in adults and children who are at least 2 years old. For children younger than 2 years old, another vaccine called Prevnar (pneumococcal conjugate vaccine [PCV] 7-valent) is used, usually given between the ages of 2 months and 15 months.
The global 23-Valent Pneumococcal Polysaccharide Vaccine market was valued at US$ 1139.5 million in 2022 and is anticipated to reach US$ 1993.7 million by 2029, witnessing a CAGR of 10.3% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Merck is the largest manufacturers of 23-Valent pneumococcal polysaccharide vaccine in the world, has a share about 78%. Other players include Sinovac, Kangtai Bio, CDIBP, Walvax, etc. United States is dominating the global 23-Valent pneumococcal polysaccharide vaccine market, has a share nearly 78% in terms of production. The largest market is United States, holds a share about 48%, followed by China and Europe, with around 25% and 22% market share respectively.

Report Scope

This report aims to provide a comprehensive presentation of the global market for 23-Valent Pneumococcal Polysaccharide Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 23-Valent Pneumococcal Polysaccharide Vaccine.
The 23-Valent Pneumococcal Polysaccharide Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global 23-Valent Pneumococcal Polysaccharide Vaccine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the 23-Valent Pneumococcal Polysaccharide Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Key Segmentations

By Company

  • Merck
  • Sinovac
  • Kangtai Bio
  • CDIBP
  • Walvax

Segment by Type

  • Single Dose Vial
  • Pre-filled Syringe

Segment by Application

  • For Children (Over 2 Years Old)
  • For Adult

Consumption by Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of 23-Valent Pneumococcal Polysaccharide Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of 23-Valent Pneumococcal Polysaccharide Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

Scope of Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Report

Report MetricDetails
Report NameGlobal 23-Valent Pneumococcal Polysaccharide Vaccine Market
Base Year2022
Forecasted years2023-2029
Forecast unitsUSD
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends
Geographic regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
1 23-Valent Pneumococcal Polysaccharide Vaccine Market Overview
1.1 Product Overview and Scope of 23-Valent Pneumococcal Polysaccharide Vaccine
1.2 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Type
1.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Value Comparison by Type (2023-2029)
1.2.2 Single Dose Vial
1.2.3 Pre-filled Syringe
1.3 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Application
1.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Value by Application: (2023-2029)
1.3.2 For Children (Over 2 Years Old)
1.3.3 For Adult
1.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Estimates and Forecasts
1.4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2018-2029
1.4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2018-2029
1.4.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 23-Valent Pneumococcal Polysaccharide Vaccine Market Competition by Manufacturers
2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of 23-Valent Pneumococcal Polysaccharide Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of 23-Valent Pneumococcal Polysaccharide Vaccine, Product Type & Application
2.7 23-Valent Pneumococcal Polysaccharide Vaccine Market Competitive Situation and Trends
2.7.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest 23-Valent Pneumococcal Polysaccharide Vaccine Players Market Share by Revenue
2.7.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 23-Valent Pneumococcal Polysaccharide Vaccine Retrospective Market Scenario by Region
3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region: 2018-2029
3.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region: 2018-2023
3.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region: 2024-2029
3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region: 2018-2029
3.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region: 2018-2023
3.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region: 2024-2029
3.4 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.4.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2018-2029)
3.4.3 North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.5.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2018-2029)
3.5.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.7.1 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2018-2029)
3.7.3 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2018-2029)
4.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2018-2023)
4.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2024-2029)
4.1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2018-2029)
4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2018-2029)
4.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2018-2023)
4.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2024-2029)
4.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2018-2029)
5.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2018-2023)
5.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2024-2029)
5.1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2018-2029)
5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2018-2029)
5.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2018-2023)
5.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2024-2029)
5.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Sinovac
6.2.1 Sinovac Corporation Information
6.2.2 Sinovac Description and Business Overview
6.2.3 Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio
6.2.5 Sinovac Recent Developments/Updates
6.3 Kangtai Bio
6.3.1 Kangtai Bio Corporation Information
6.3.2 Kangtai Bio Description and Business Overview
6.3.3 Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio
6.3.5 Kangtai Bio Recent Developments/Updates
6.4 CDIBP
6.4.1 CDIBP Corporation Information
6.4.2 CDIBP Description and Business Overview
6.4.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio
6.4.5 CDIBP Recent Developments/Updates
6.5 Walvax
6.5.1 Walvax Corporation Information
6.5.2 Walvax Description and Business Overview
6.5.3 Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio
6.5.5 Walvax Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 23-Valent Pneumococcal Polysaccharide Vaccine Industry Chain Analysis
7.2 23-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 23-Valent Pneumococcal Polysaccharide Vaccine Production Mode & Process
7.4 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Marketing
7.4.1 23-Valent Pneumococcal Polysaccharide Vaccine Sales Channels
7.4.2 23-Valent Pneumococcal Polysaccharide Vaccine Distributors
7.5 23-Valent Pneumococcal Polysaccharide Vaccine Customers
8 23-Valent Pneumococcal Polysaccharide Vaccine Market Dynamics
8.1 23-Valent Pneumococcal Polysaccharide Vaccine Industry Trends
8.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Drivers
8.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Challenges
8.4 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Competitive Situation by Manufacturers in 2022
    Table 4. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) of Key Manufacturers (2018-2023)
    Table 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market 23-Valent Pneumococcal Polysaccharide Vaccine Average Price (USD/Unit) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of 23-Valent Pneumococcal Polysaccharide Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of 23-Valent Pneumococcal Polysaccharide Vaccine, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of 23-Valent Pneumococcal Polysaccharide Vaccine, Product Type & Application
    Table 12. Global Key Manufacturers of 23-Valent Pneumococcal Polysaccharide Vaccine, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 23-Valent Pneumococcal Polysaccharide Vaccine as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2018-2023) & (K Units)
    Table 18. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2018-2023)
    Table 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2024-2029) & (K Units)
    Table 20. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2024-2029)
    Table 21. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2018-2023)
    Table 23. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2024-2029)
    Table 25. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2018-2023) & (K Units)
    Table 27. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2024-2029) & (K Units)
    Table 28. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2018-2023) & (K Units)
    Table 32. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2024-2029) & (K Units)
    Table 33. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2018-2023) & (K Units)
    Table 37. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2024-2029) & (K Units)
    Table 38. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2018-2023) & (K Units)
    Table 42. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2024-2029) & (K Units)
    Table 43. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2018-2023) & (K Units)
    Table 47. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2024-2029) & (K Units)
    Table 48. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) by Type (2018-2023)
    Table 51. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) by Type (2024-2029)
    Table 52. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2018-2023)
    Table 53. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2024-2029)
    Table 54. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2018-2023)
    Table 57. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2024-2029)
    Table 58. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Unit) by Type (2018-2023)
    Table 59. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Unit) by Type (2024-2029)
    Table 60. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) by Application (2018-2023)
    Table 61. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) by Application (2024-2029)
    Table 62. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2018-2023)
    Table 63. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2024-2029)
    Table 64. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2018-2023)
    Table 67. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2024-2029)
    Table 68. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Unit) by Application (2018-2023)
    Table 69. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Unit) by Application (2024-2029)
    Table 70. Merck Corporation Information
    Table 71. Merck Description and Business Overview
    Table 72. Merck 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 73. Merck 23-Valent Pneumococcal Polysaccharide Vaccine Product
    Table 74. Merck Recent Developments/Updates
    Table 75. Sinovac Corporation Information
    Table 76. Sinovac Description and Business Overview
    Table 77. Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 78. Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Product
    Table 79. Sinovac Recent Developments/Updates
    Table 80. Kangtai Bio Corporation Information
    Table 81. Kangtai Bio Description and Business Overview
    Table 82. Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 83. Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Product
    Table 84. Kangtai Bio Recent Developments/Updates
    Table 85. CDIBP Corporation Information
    Table 86. CDIBP Description and Business Overview
    Table 87. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 88. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product
    Table 89. CDIBP Recent Developments/Updates
    Table 90. Walvax Corporation Information
    Table 91. Walvax Description and Business Overview
    Table 92. Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 93. Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Product
    Table 94. Walvax Recent Developments/Updates
    Table 95. Key Raw Materials Lists
    Table 96. Raw Materials Key Suppliers Lists
    Table 97. 23-Valent Pneumococcal Polysaccharide Vaccine Distributors List
    Table 98. 23-Valent Pneumococcal Polysaccharide Vaccine Customers List
    Table 99. 23-Valent Pneumococcal Polysaccharide Vaccine Market Trends
    Table 100. 23-Valent Pneumococcal Polysaccharide Vaccine Market Drivers
    Table 101. 23-Valent Pneumococcal Polysaccharide Vaccine Market Challenges
    Table 102. 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints
    Table 103. Research Programs/Design for This Report
    Table 104. Key Data Information from Secondary Sources
    Table 105. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of 23-Valent Pneumococcal Polysaccharide Vaccine
    Figure 2. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Type in 2022 & 2029
    Figure 4. Single Dose Vial Product Picture
    Figure 5. Pre-filled Syringe Product Picture
    Figure 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Application in 2022 & 2029
    Figure 8. For Children (Over 2 Years Old)
    Figure 9. For Adult
    Figure 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (2018-2029) & (US$ Million)
    Figure 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (2018-2029) & (K Units)
    Figure 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price (USD/Unit) & (2018-2029)
    Figure 14. 23-Valent Pneumococcal Polysaccharide Vaccine Report Years Considered
    Figure 15. 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers in 2022
    Figure 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers in 2022
    Figure 17. The Global 5 and 10 Largest 23-Valent Pneumococcal Polysaccharide Vaccine Players: Market Share by Revenue in 2022
    Figure 18. 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 20. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2018-2029)
    Figure 21. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2018-2029)
    Figure 22. United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 23. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 24. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2018-2029)
    Figure 25. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2018-2029)
    Figure 26. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 27. France 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 28. U.K. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 29. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 30. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 31. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2018-2029)
    Figure 32. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2018-2029)
    Figure 33. China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 34. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 35. South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 36. India 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 37. Australia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 38. China Taiwan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. Indonesia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. Thailand 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Malaysia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2018-2029)
    Figure 43. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2018-2029)
    Figure 44. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 45. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 46. Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 47. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2018-2029)
    Figure 48. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2018-2029)
    Figure 49. Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 51. UAE 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 52. Global Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2018-2029)
    Figure 53. Global Revenue Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2018-2029)
    Figure 54. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Unit) by Type (2018-2029)
    Figure 55. Global Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Application (2018-2029)
    Figure 56. Global Revenue Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Application (2018-2029)
    Figure 57. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Unit) by Application (2018-2029)
    Figure 58. 23-Valent Pneumococcal Polysaccharide Vaccine Value Chain
    Figure 59. 23-Valent Pneumococcal Polysaccharide Vaccine Production Process
    Figure 60. Channels of Distribution (Direct Vs Distribution)
    Figure 61. Distributors Profiles
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS